Literature DB >> 6104123

Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.

D L Coulter, R J Allen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6104123     DOI： 10.1016/s0140-6736(80)91773-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

1.  Simultaneous side effects of both clozapine and valproate.

Authors:  J Nicolai; S J Smith; R W Keunen
Journal:  Intensive Care Med       Date:  2001-05       Impact factor: 17.440

2.  Valproic acid-associated encephalopathy.

Authors:  G L Jones; F Matsuo; J R Baringer; W H Reichert
Journal:  West J Med       Date:  1990-08

3.  Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs.

Authors:  R N Ratnaike; G J Schapel; G Purdie; R H Rischbieth; S Hoffmann
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

4.  A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver.

Authors:  Saleh Alqahtani; Paolo Federico; Robert P Myers
Journal:  CMAJ       Date:  2007-09-11       Impact factor: 8.262

Review 5.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

6.  Characteristics of glutamine metabolism in human precision-cut kidney slices: a 13C-NMR study.

Authors:  Anne Vittorelli; Catherine Gauthier; Christian Michoudet; Guy Martin; Gabriel Baverel
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

7.  Rapid Rescue From Hyperammonemic Coma After Valproic Acid Poisoning: Dual Therapy With Continuous Renal Replacement Therapy and L-Carnitine Supplementation.

Authors:  Shyam Kiran Gandam Venkata; Kenneth Guillotte; BreeAnna Murphy; Sai Sruthi Bhuram; Sudeep Chakravarthy Bhuram
Journal:  Cureus       Date:  2021-06-27

8.  Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA.

Authors:  F X Coude; G Grimber; P Parvy; D Rabier; F Petit
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

9.  Impairment of consciousness induced by valproate treatment following neurosurgical operation.

Authors:  J Landau; M Baulac; G Durand; A de Billy; J Philippon
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 10.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.